The USFDA has accepted for filing Astellas Pharma's supplemental new drug application (sNDA) for Tarceva (erlotinib) tablets for a genetically distinct form of advanced lung cancer. Astellas is seeking approval to use Tarceva as the ...
Human breath contains a range of volatile organic components,which can help to provide useful information for diagnosis of various diseases,it has been found. The Korea Advanced Institute of Science and Technology has reached a new ...
Fashion Emerge is the host along with affiliates Mae’s Breath Foundation. The event will celebrate the 1st anniversary of this thriving organization that is making small steps in building awareness in lung cancer. Mae’s Breath ...
Tags: Fashion Emerge, affiliates Mae, Breath Foundation, lung cancer
The winners of a free software app created at the first NHS Hack Day claim their product could save the NHS £3m per year in lost time. The browser-based Patient List system is intended to reduce the number of mistakes made in care ...
Tags: software app, Patient List app, NHS Hack Day, electronic medical records
MIT researchers are using nanotechnology to help doctors detect cancer in their patients sooner, increasing their odds of beating the disease. To diagnose cancer, doctors look for specific proteins secreted by cancer cells. The problem ...
Tags: MIT, nanotechnology, detect cancer, specific proteins
Enzo Biochem's Clinical Labs has launched a new diagnostic test, designed to assess and detect lung cancer at earlier stages, in New York metropolitan market as well as New Jersey and Eastern Pennsylvania, US. Using a panel of tumor ...
Tags: Enzo Biochem, diagnostic test, EarlyCDT-Lung test, EarlyCDT-Lung
Allegro Diagnostics is set to present results of its BronchoGen genomic test, from Airway Epithelium Gene Expression In the Diagnosis of Lung Cancer (AEGIS) clinical trials, in a late-breaking abstract session at CHEST to be held on 23 ...
Clarient Diagnostic Services, a GE Healthcare company, has entered into an agreement to license genomic biomarker for lung cancer from Insight Genetics. AS per the agreement, Clarient intends to develop and assess the performance ...
Tags: Lung Cancer, cooperation, medical technology
The US Patent and Trademark Office (USPTO) has granted a notice of allowance (NOA) to Sanovas' minimally invasive nested balloon catheter for localized drug delivery. The patent will protect an integral part of the company's NanoVas ...
Tags: USPTO, NOA, minimally invasive nested balloon catheter, medical product
Scientists at Princeton University say they have used nanotechnology to make tests to detect diseases,such as cancer and Alzheimer's,3 million times more sensitive. That means what researchers are calling a breakthrough in nanotechnology ...
Tags: nanotechnology, detect diseases, Princeton University, D2PA, Cancer
Allegro Diagnostics has completed patient enrollment in 1,320-patient Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer II (AEGIS II) trial for BronchoGen genomic test. BronchoGen, which is built on the company's ...
Tags: clinical trial, clinical research, lung cancer molecular diagnostic
Astellas Pharma US is seeking FDA approval for Tarceva tablets to treat non-small cell lung cancer patients (NSCLC) with tumors containing epidermal growth factor receptor (EGFR) that triggers mutations. The company submitted a ...
Ventana Medical Systems, a member of the Roche Group, has launched a new fully-automated staining technique that allows researchers to visualize miRNAs and proteins related to cancer in the same section of tumor tissue. Detection of ...
Tags: Ventana, staining technique, cancer detection, miRNAs
Multinational biopharmaceutical company Celgene has received US Food and Drug Administration (FDA) approval for Abraxane, which is aimed to treat locally advanced or metastatic non-small cell lung cancer in combination with carboplatin in ...
Tags: Abraxane, lung cancer, Multinational biopharmaceutical company Celgene
Proacta, a San Diego based biotechnology company, has announced FDA approval of investigational new drug (IND) application for PR610, a hypoxia-activated irreversible multi-kinase inhibitor, for the treatment of cancer. With the IND ...
Tags: investigational new drug, IND